Calumet Specialty Products
CLMT
61 hedge funds and large institutions have $86.4M invested in Calumet Specialty Products in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 6 closing their positions.
481% more call options, than puts
Call options by funds: $8.13M | Put options by funds: $1.4M
116% more capital invested
Capital invested by funds: $40.1M → $86.4M (+$46.3M)
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
42% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 12
11% more funds holding
Funds holding: 55 → 61 (+6)
1.61% more ownership
Funds ownership: 16.41% → 18.02% (+1.6%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$1.54M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.09M |
| 3 |
DMK
David M. Knott
|
+$835K |
| 4 |
Goldman Sachs
New York
|
+$702K |
| 5 |
EGA
Evermore Global Advisors
Summit,
New Jersey
|
+$598K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HT
HAP Trading
New York
|
-$312K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$280K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$144K |
| 4 |
OBGC
O'Brien Greene & Co
Media,
Pennsylvania
|
-$103K |
| 5 |
Citigroup
New York
|
-$52.7K |
CLMT Hedge Fund Activity: Q1 2021 in Review
61 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Calumet Specialty Products (CLMT) for Q1 2021, worth a combined $86.4M — up 116% from $40.1M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new CLMT positions and 6 closed out — a net gain of 6 holders — while 17 added to existing stakes and 12 trimmed.
The largest buyer was Caption Management, opening a new position worth an estimated $1.54M. The largest seller was HAP Trading, exiting entirely with an estimated $312K sold.
- 61 institutional investors held Calumet Specialty Products (CLMT) as of Q1 2021, up from 55 in Q4 2020.
- Funds reported $86.4M of Calumet Specialty Products stock for Q1 2021, up 116% quarter-over-quarter.
- 12 funds opened new Calumet Specialty Products positions in Q1 2021 and 6 closed out, a net change of +6 holders.
- The largest Calumet Specialty Products buyer in Q1 2021 was Caption Management, an estimated $1.54M added.
- The largest Calumet Specialty Products seller in Q1 2021 was HAP Trading, an estimated $312K sold.
Based on aggregated 13F filings for Q1 2021.